RESUMEN
Mutations in the androgen receptor gene are considered as incompatible with preservation of fertility and have been suggested as a cause of male infertility. Two adult brothers, referred because of gynecomastia and hormonal levels in serum indicating androgen insensitivity (high sex hormone-binding globulin, and LH levels, despite extremely high testosterone concentration), turned out to be relatives to a third young man, referred independently of the two others and exhibiting identical clinical and hormonal stigmata. In all three men, we found a C-->A substitution at position 2470 (exon 7) in the androgen receptor gene, leading to a Gln824Lys mutation in the ligand-binding domain of the receptor. Exploring the family history revealed that their grandfathers, on their mothers' side, were brothers; and the Gln824Lys mutation was also found in the one of them who was still alive. Binding studies with the mutant receptor in transfected COS-7 cells, with mibolerone as ligand, exhibited equal Kd (0.7 vs. 1.0 nmol/ L), IC50 (0.8 vs. 1.1 nmol/L), and maximum binding (7.1 vs. 8.9 fmol/ 10(6) cells), as compared with the wild-type (WT) receptor. In a chloramphenicol acetyl transferase trans-activation assay, the activity of the mutant receptor was identical to that of the WT, when the synthetic androgen R1881 was'used as a ligand; but with dihydrotestosterone, in concentrations up to 10 nmol/L, the activity of Gln824Lys mutated receptor was 10-62% of the WT variant. Thus, Gln824Lys mutation was found, both in vivo and in vitro, to cause slight impairment of receptor function but was compatible with preservation of male fertility. The patients inherited the mutation from their grandfathers through their mothers, and one of the young men possessing the mutation has fathered a daughter.
Asunto(s)
Fertilidad/fisiología , Ginecomastia/genética , Ginecomastia/fisiopatología , Mutación Puntual , Receptores Androgénicos/genética , Adulto , Sustitución de Aminoácidos , Animales , Sitios de Unión , Células CHO , Cricetinae , Estradiol/sangre , Exones , Femenino , Fertilidad/genética , Hormona Folículo Estimulante/sangre , Ginecomastia/sangre , Humanos , Inhibinas/sangre , Hormona Luteinizante/sangre , Masculino , Núcleo Familiar , Linaje , Receptores Androgénicos/química , Receptores Androgénicos/metabolismo , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Globulina de Unión a Hormona Sexual/análisis , Recuento de Espermatozoides , Testículo/anatomía & histología , Testosterona/sangre , TransfecciónRESUMEN
Insulin-like growth factor-binding protein 6 (IGFBP6), an extracellular protein with preferential affinity for insulin-like growth factor (IGF) II, belongs to a family of binding proteins with at least six members. We have characterized the genomic structure and the chromosomal location of the human IGFBP6, which is present in the human genome as a single-copy gene spanning 4.7 kb. It consists of four exons, encoding the translated regions, with sizes of 334, 146, 120, and 123 bp, while the intervening introns are 2661, 182, and 844 bp. Three mRNA cap sites were localized 101, 100, and 96 bp upstream of the ATG translation start codon as determined by S1 nuclease analysis. The proximal 5'-flanking region does not have any TATA or CAAT consensus sequences. The IGFBP6 was localized to Chr 12 by analysis of somatic cell hybrids and regionalized to 12q13 by fluorescence DNA in situ hybridization.
Asunto(s)
Cromosomas Humanos Par 12 , Genoma Humano , Proteína 6 de Unión a Factor de Crecimiento Similar a la Insulina/genética , Secuencia de Aminoácidos , Mapeo Cromosómico , Exones/genética , Humanos , Hibridación in Situ , Datos de Secuencia Molecular , ARN Mensajero/genética , Análisis de SecuenciaRESUMEN
Insulin-like growth factor binding protein 4 (IGFBP-4) is locally produced by normal human bone cells and acts as a potent inhibitor of IGF action in this tissue. PTH and a cAMP analog increase the expression of IGFBP4 mRNA in human osteoblast cells. We now show that the human IGFBP4 gene is contained within 15.3 kb with the transcription initiation site located 28 bp downstream of a TATA box sequence and 286 bp upstream of the translation initiation codon. The 3'-end of the mRNA was identified at position 14281, but no conserved poly(A) addition signal was found within 30 bp upstream of this site. Deletion mutagenesis located the core promoter activity downstream of position -289, and the transcription activity disappeared at -6. Stimulation with 0.5 mM dibutyryl-cAMP resulted in a twofold increase of promoter activity. Elements responsible for the cAMP response reside between positions -869 and -6.
Asunto(s)
Regulación de la Expresión Génica , Proteína 4 de Unión a Factor de Crecimiento Similar a la Insulina/biosíntesis , Proteína 4 de Unión a Factor de Crecimiento Similar a la Insulina/genética , Regiones Promotoras Genéticas , Transcripción Genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Bucladesina/farmacología , Células Cultivadas , Clonación Molecular , Codón , AMP Cíclico/metabolismo , Humanos , Proteína 4 de Unión a Factor de Crecimiento Similar a la Insulina/química , Luciferasas/biosíntesis , Datos de Secuencia Molecular , Osteoblastos/metabolismo , Regiones Promotoras Genéticas/efectos de los fármacos , Biosíntesis de Proteínas , Ratas , Proteínas Recombinantes de Fusión/biosíntesis , Proteínas Recombinantes de Fusión/química , Alineación de Secuencia , Homología de Secuencia de Ácido Nucleico , TATA BoxRESUMEN
The gene for insulin-like growth factor-binding protein 4 (IGFBP4) codes for a serum protein that binds to the family of insulin-like growth factors and modulates their activity. It has been mapped by in situ hybridization to chromosome region 17q12-q21.1. We have developed a CA-repeat polymorphism from a cosmid clone containing IGFBP4. By linkage analysis, IGFBP4 maps to the chromosome 17q interval THRA1-D17S579. This interval also contains the gene for hereditary breast-ovarian cancer, BRCA1. Genetic recombination between IGFBP4 and BRCA1 places IGFBP4 centromeric to the cancer susceptibility gene and effectively excludes it as a candidate gene for BRCA1. IGFBP4 is, however, one of the closest known centromeric markers for BRCA1; the estimated recombination fraction is 0.015. IGFBP4 and D17S579 together define a 2.8-cM interval that contains BRCA1.
Asunto(s)
Neoplasias de la Mama/genética , Proteínas Portadoras/genética , Cromosomas Humanos Par 17 , Neoplasias Ováricas/genética , Somatomedinas , Secuencia de Bases , Mapeo Cromosómico , Femenino , Humanos , Proteína 4 de Unión a Factor de Crecimiento Similar a la Insulina , Escala de Lod , Masculino , Datos de Secuencia Molecular , Linaje , Reacción en Cadena de la PolimerasaRESUMEN
The insulin-like growth factor binding proteins (IGFBPs) constitute a structurally related protein family with six known members. We have mapped and regionally localized the genes coding for human IGFBP1, 2, 3, and 4, by in situ hybridization and somatic cell hybrid analysis. The IGFBP2 gene maps to chromosomal region 2q33-q34 whereas the genes for IGFBP1 and 3 are localized in a tail-to-tail fashion on chromosome 7 region p14-p12. The IGFBP4 gene is located in the chromosomal region 17q12-21.1. Structural characterization of the genes coding for IGFBP-1, 2, 3, and 5 showed that the translated parts are divided into four exons. The exons are similar both in size and sequence in all studied genes.
Asunto(s)
Proteínas Portadoras/genética , Mapeo Cromosómico , Somatomedinas , Secuencia de Aminoácidos , Secuencia de Bases , Proteínas Portadoras/análisis , Cromosomas Humanos Par 17 , Cromosomas Humanos Par 2 , Cromosomas Humanos Par 7 , ADN/análisis , ADN/aislamiento & purificación , Humanos , Células Híbridas , Hibridación in Situ , Proteínas de Unión a Factor de Crecimiento Similar a la Insulina , Datos de Secuencia Molecular , Reacción en Cadena de la PolimerasaRESUMEN
The disulfide arrangement of yeast derived human insulin-like growth factor I (yIGF-I) was determined using a combination of Staphylococcus aureus V8 protease mapping, fast-atom-bombardment mass spectrometry as well as amino acid sequence and composition analysis. Three disulfide bridges were found between the following cysteine residues: Cys6-Cys48, Cys47-Cys52 and Cys18-Cys61. IGF-I isolated from human plasma (pIGF-I) was found to have an identical disulfide configuration. A yeast-derived isomeric form of IGF-I (yisoIGF-I) exhibited an altered disulfide arrangement: Cys6-Cys47, Cys48-Cys52 and Cys18-Cys61. Radioreceptor analysis of pIGF-I and yIGF-I showed high specific activity, 20,000 U/mg. However, yisoIGF-I demonstrated a severely reduced ability to bind to the IGF-I receptor (19%) and was less potent in provoking a mitogenic response in Balb/C 3T3 fibroblasts (50% at doses 10-100 ng/ml). The data demonstrate the importance of correct disulfide arrangement in IGF-I for full biological activity.